• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 3. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 4. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 5. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053

Introduction to 4-(3R)-pyrrolidin-3-yloxypyridine hydrochloride (CAS No. 1264033-82-0)

4-(3R)-pyrrolidin-3-yloxypyridine hydrochloride is a sophisticated organic compound that has garnered significant attention in the field of pharmaceutical chemistry and drug discovery. This compound, identified by its unique Chemical Abstracts Service (CAS) number 1264033-82-0, represents a promising scaffold for the development of novel therapeutic agents. Its molecular structure, featuring a pyrrolidine ring linked to a pyridine moiety through an ether oxygen atom, positions it as a versatile intermediate in medicinal chemistry. The presence of the hydrochloride salt form enhances its solubility and bioavailability, making it an attractive candidate for further pharmacological investigation.

The significance of 4-(3R)-pyrrolidin-3-yloxypyridine hydrochloride lies in its potential applications across multiple therapeutic domains. Recent advancements in drug design have highlighted the importance of heterocyclic compounds in addressing complex diseases. The pyrrolidine and pyridine fragments are both well-documented motifs in bioactive molecules, contributing to their ability to interact with biological targets such as enzymes and receptors. The chiral center at the 3-position of the pyrrolidine ring, specifically the (3R) configuration, adds another layer of complexity and specificity to the compound’s pharmacological profile.

In the context of modern medicinal chemistry, the development of selective and potent inhibitors is paramount. 4-(3R)-pyrrolidin-3-yloxypyridine hydrochloride has been explored as a key intermediate in synthesizing molecules that modulate key biological pathways. For instance, its structural framework has been leveraged in the design of compounds targeting neurological disorders, where precise modulation of receptor activity is crucial. The ether linkage between the pyrrolidine and pyridine rings not only contributes to the molecule’s overall stability but also provides a site for functionalization, enabling chemists to tailor its properties for specific applications.

Recent studies have demonstrated the compound’s utility in preclinical models as a potential scaffold for antiviral and anti-inflammatory agents. The pyrrolidine ring is known to be present in several FDA-approved drugs, underscoring its importance as a pharmacophore. By incorporating this motif into 4-(3R)-pyrrolidin-3-yloxypyridine hydrochloride, researchers aim to harness its inherent biological activity while exploring new therapeutic possibilities. The hydrochloride salt form further enhances its pharmacokinetic properties, facilitating better absorption and distribution within the body.

The synthesis of 4-(3R)-pyrrolidin-3-yloxypyridine hydrochloride involves multi-step organic transformations that require precise control over reaction conditions. The chiral purity of the compound is particularly critical, as even minor enantiomeric impurities can significantly impact its biological activity. Advanced synthetic methodologies, including asymmetric catalysis and chiral resolution techniques, have been employed to ensure high enantiomeric excess (ee) values. These efforts underscore the compound’s complexity and the meticulous approach required in its preparation.

From a computational chemistry perspective, 4-(3R)-pyrrolidin-3-yloxypyridine hydrochloride has been subjected to extensive molecular modeling studies to elucidate its interactions with biological targets. These studies provide valuable insights into its binding affinity and mode of action, guiding further optimization efforts. The integration of machine learning algorithms has accelerated the process of identifying potential lead compounds derived from this scaffold. By leveraging large datasets and predictive models, researchers can rapidly screen thousands of analogs, streamlining the drug discovery pipeline.

The pharmaceutical industry has shown particular interest in heterocyclic compounds due to their diverse biological activities and structural versatility. 4-(3R)-pyrrolidin-3-yloxypyridine hydrochloride exemplifies this trend by combining two pharmacologically relevant moieties into a single molecule. Its potential as an intermediate for synthesizing novel therapeutics has prompted collaborations between academic institutions and pharmaceutical companies. These partnerships aim to translate laboratory findings into clinical candidates with tangible therapeutic benefits.

In conclusion, 4-(3R)-pyrrolidin-3-yloxypyridine hydrochloride (CAS No. 1264033-82-0) represents a significant advancement in medicinal chemistry research. Its unique structural features and promising pharmacological profile make it a valuable asset in the quest for new treatments for various diseases. As research continues to uncover new applications for this compound, it is expected to play an increasingly important role in drug development efforts worldwide.

• 1038351-48-2(3-(3-Pyridinyloxy)piperidine dihydrochloride)
• 224178-65-8(4-(Piperidin-4-yloxy)pyridine)
• 308386-36-9(4-(Piperidin-4-yloxy)pyridine dihydrochloride)
• 933716-88-2(4-(pyrrolidin-3-yloxy)pyridine)
• 224818-27-3(3-(pyrrolidin-3-yloxy)pyridine)
• 310880-83-2(3-[(3S)-3-PYRROLIDINYLOXY]-PYRIDINE DIHYDROCHLORIDE)
• 1171481-61-0(4-(Piperidin-3-yloxy)pyridine Dihydrochloride)
• 933701-61-2(4-(piperidin-3-yloxy)pyridine)
• 1314355-43-5((S)-4-(Pyrrolidin-3-yloxy)pyridine hydrochloride)
• 1185083-43-5(3-(3-Pyrrolidinyloxy)pyridine Dihydrochloride)